Yudy Tjahjono

Surabaya, JI 60237, Indonesia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Combined inulin, glucomannan, and medium-chain triglyceride modulate metabolic and inflammatory responses in chemotherapy-treated colorectal cancer cells.

Combined inulin, glucomannan, and medium-chain triglyceride modulate metabolic and inflammatory responses in chemotherapy-treated colorectal cancer cells.

Journal: Journal of advanced pharmaceutical technology & research

Published: February 11, 2026

Combined inulin and glucomannan modulate colonic cytokine balance and mucosal barrier function in a western diet-induced colonic inflammation mouse model.

Combined inulin and glucomannan modulate colonic cytokine balance and mucosal barrier function in a western diet-induced colonic inflammation mouse model.

Journal: Journal of advanced pharmaceutical technology & research

Published: February 10, 2026

Peroxisomes, PPARs, and Their Role in Macrophages.

Peroxisomes, PPARs, and Their Role in Macrophages.

Journal: Cells

Published: October 24, 2025

Development of a synbiotic water kefir, dragon fruit, and inulin-medium-chain triglyceride drink as a candidate for an antihyperlipidemic beverage.

Development of a synbiotic water kefir, dragon fruit, and inulin-medium-chain triglyceride drink as a candidate for an antihyperlipidemic beverage.

Journal: Journal of advanced pharmaceutical technology & research

Published: September 25, 2025

2-((3-(chloromethyl) benzoyl) oxy) benzoic acid suppresses NF-κB expression in the kidneys and lungs of LPS-Induced BALB/C mice.

2-((3-(chloromethyl) benzoyl) oxy) benzoic acid suppresses NF-κB expression in the kidneys and lungs of LPS-Induced BALB/C mice.

Journal: Journal of advanced pharmaceutical technology & research

Published: March 12, 2025

2-(3-(Chloromethyl)benzoyloxy)benzoic Acid reduces prostaglandin E-2 concentration, NOX2 and NFKB expression, ROS production, and COX-2 expression in lipopolysaccharide-induced mice.

2-(3-(Chloromethyl)benzoyloxy)benzoic Acid reduces prostaglandin E-2 concentration, NOX2 and NFKB expression, ROS production, and COX-2 expression in lipopolysaccharide-induced mice.

Journal: Prostaglandins & other lipid mediators

Published: March 25, 2024

Glucomannan is a promising isoniazid's enhancer that inducing macrophage phagocytosis.

Glucomannan is a promising isoniazid's enhancer that inducing macrophage phagocytosis.

Journal: Journal of advanced pharmaceutical technology & research

Published: March 14, 2024

Acceleration of wound healing using adipose mesenchymal stem cell secretome hydrogel on partial-thickness cutaneous thermal burn wounds: An in vivo study in rats.

Acceleration of wound healing using adipose mesenchymal stem cell secretome hydrogel on partial-thickness cutaneous thermal burn wounds: An in vivo study in rats.

Journal: Veterinary world

Published: March 05, 2024

Characterization of 2-((4-(chloromethyl)benzoyl)oxy)benzoate acid for analgesic tablet dosage form formulation.

Characterization of 2-((4-(chloromethyl)benzoyl)oxy)benzoate acid for analgesic tablet dosage form formulation.

Journal: Current research in pharmacology and drug discovery

Published: October 08, 2023

The combination of isomalto-oligosaccharides (IMO)-based dietary fiber and hypocaloric high-protein diet could improve the anthropometric profile and fasting plasma glucose of healthy adults: A repeated single-arm clinical trial.

The combination of isomalto-oligosaccharides (IMO)-based dietary fiber and hypocaloric high-protein diet could improve the anthropometric profile and fasting plasma glucose of healthy adults: A repeated single-arm clinical trial.

Journal: Contemporary clinical trials communications

Published: September 27, 2022

Characterization of chemokine and cytokine expression pattern in tuberculous lymphadenitis patient.

Characterization of chemokine and cytokine expression pattern in tuberculous lymphadenitis patient.

Journal: Frontiers in immunology

Published: July 01, 2022

Managing spondylitis tuberculosis in a patient with underlying diabetes and hypothyroidism: A case report.

Managing spondylitis tuberculosis in a patient with underlying diabetes and hypothyroidism: A case report.

Journal: World journal of clinical cases

Published: October 31, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026